Sativex, an oral spray containing both CBD and THC, can treat MS-induced pain. During one study, researchers gave Sativex to 47 participants with MS. Results were largely positive. Patients who used this spray felt notably better. Their muscle and walking spasms decreased, and they felt pain relief. Thanks to studies such as this one, several countries approved using Sativex in MS treatment.
“Research shows that CBD content decreases when it is exposed to heat. It’s likely that the reduction in efficacy is due to the lower content. For instance, studies show that 71 degrees F can accelerate the degradation of CBD in a solution, resulting in less CBD. Potentially adding CBD to hot coffee may degrade it and reduce the amount of CBD available for absorption."

Until 2017, products containing cannabidiol that are marketed for medical purposes were classed as medicines by the UK regulatory body, the Medicines and Healthcare products Regulatory Agency (MHRA) and could not be marketed without regulatory approval for the medical claims.[89][90] CBD oil with THC content not exceeding 0.2% was legalized throughout the UK in 2017.[citation needed] Cannabis oil, however, remained illegal to possess, buy and sell.[91]

Various studies done on CBD oils and other cannabis products around the world have come to similar conclusions about incorrect label information [24, 53, 54] and the presence of contaminants [54-57]. In the absence of a clear legal status for CBD, or agreement on common safety and quality standards, it may not be surprising that current CBD products leave something to be desired. The time has come for regulators to give CBD the attention it deserves in order to ensure that affordable, safe, and reliable CBD products are available to those who depend on them.
Several studies have found that the use of CBD oil is helpful in reducing anxiety, meaning it could be a beneficial natural remedy for sufferers. Back in 2011, a study published in the journal Neuropsychopharmacology found that when people with generalised social anxiety disorder (SAD) were given 600mg of CBD oil prior to a public speaking test, as opposed to a placebo, they experienced significantly less anxiety, difficulty and discomfort during their speech.
There is a significant amount of scientific research on CBD and the ECS system as well as journal entries from pilot studies done by doctors from around the world over the past four decades. However, as this is still a novel area of medicine, do your own research on CBD. There are many online sources of information, but note the internet has a mix of both valid and misleading data. Vet your sources to ensure that they are reputable.

Effective in January 2017, the DEA (which typically refers to marijuana by the plant’s scientific species name, Cannabis sativa, or the Reefer Madness-era spelling “marihuana”) made a rule stating its marijuana scheduling includes “marihuana extract.” In the rule, the agency defined “marihuana extract” as an “extract containing one or more cannabinoids that has been derived from any plant of the genus Cannabis”—which would include CBD.

Cannabidiol is currently a class B1 controlled drug in New Zealand under the Misuse of Drugs Act. It is also a prescription medicine under the Medicines Act. In 2017 the rules were changed so that anyone wanting to use it could go to the Health Ministry for approval. Prior to this, the only way to obtain a prescription was to seek the personal approval of the Minister of Health.

CBD Oil

×